Compounded semaglutide at $199 per month remains the most affordable ongoing option, matching the introductory cash-pay price as a permanent rate
Competing interests MJD reported board membership and consultancy fees from Novo Nordisk, Sanofi-Aventis, Lilly, Merck, Sharp & Dohme, Boehringer Ingelheim, AstraZeneca, Servier, and Janssen
New users of GLP-1 RAs were compared with new users of other glucose-lowering drugs
As patents evolve and global pharmaceutical markets shift, conversations about lower-cost GLP-1 therapies are gaining momentum
Track fluid intake, log urine color, get time-based reminders to sip, and match hydration targets to your weight and activity level so you know how much water to drink on semaglutide without guessing